Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?
10:33am, Wednesday, 07'th Jun 2023
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
2 Dividend Kings Down 12% and 14% You'll Regret Not Buying on The Dip
10:15am, Sunday, 04'th Jun 2023
Abbott Labs and Johnson & Johnson have raised their payouts for 51 and 60 consecutive years, respectively. Both companies have solid businesses and a proven ability to be successful in the tricky heal
Abbott accuses one of its former scientists of trade-secrets theft in US court
11:51am, Wednesday, 31'st May 2023
Healthcare company Abbott Laboratories on Tuesday sued one of its former scientists, accusing him in U.S. court of "secretly downloading" sensitive corporate files containing competitive information a
Abbott (ABT) Reports Upbeat Cardiomems Sensor Study Result
10:40am, Tuesday, 30'th May 2023
Abbott's (ABT) MONITOR-HF is the third randomized, controlled trial that will provide significant health benefits to indicated heart failure patients.
Buy Alert: 3 Undervalued High-Yield Gems For Your Retirement
09:00am, Friday, 26'th May 2023
This article discusses three high-yielding stocks for retirees and income-oriented investors: ONEOK, AbbVie, and Realty Income. ONEOK is a cyclical income play with a 6.5% yield, AbbVie offers a high-
How Dexcom and Abbott are moving beyond diabetes with blood sugar monitoring
08:00am, Friday, 26'th May 2023
CNBC spoke with both Abbott and Dexcom about the technology inside continuous glucose monitors and how they see the technology expanding.
Medical technology is a good space for cover in recession times, says Mizuho's Anthony Petrone
02:52pm, Wednesday, 24'th May 2023
Anthony Petrone, senior medical devices analyst at Mizuho, joins 'The Exchange' to discuss medical technology gaining share, the bull case for Medtronic, and how medication advancements could impact t
Abbott (ABT) Unveils Late-Breaking Data on Leadless Pacemaker
01:13pm, Wednesday, 24'th May 2023
Abbott (ABT) study analyzes primary safety and efficacy endpoints in the first 300 people enrolled across 55 centers in the United States, Canada and Europe.
FTC Investigates Abbott For Alleged Collusion in Federal Baby Formula Contract Bids
12:40pm, Wednesday, 24'th May 2023
Abbott, the nation's largest maker of infant formula, is being investigated by the Federal Trade Commission for potentially anti-competitive federal nutrition program bids.
10 A-Rated Dividend Aristocrats For The Ultimate High-Yield SWAN Portfolio
07:20am, Wednesday, 24'th May 2023
The debt ceiling crisis is coming down to the wire. We're possibly already out of time to prevent default and just don't know it. UBS estimates a short default could create a 20% bear market and a one
Abbott, other formula makers face FTC investigation for collusion - WSJ
12:33am, Wednesday, 24'th May 2023
The U.S. Federal Trade Commission is investigating whether baby-formula makers colluded on bids for attractive state contracts, the Wall Street Journal reported on Wednesday.
Abbott Laboratories: A Mixed, Yet Expensive Bag
06:04pm, Monday, 22'nd May 2023
Abbott Laboratories is suffering from a reversal of pandemic trends and its own issues around pediatric nutrition. This creates a tough setup for 2023, as valuations remain demanding.
Judge tosses some claims in Abbott baby formula litigation
06:02pm, Monday, 22'nd May 2023
Abbott Laboratories persuaded a federal judge to dismiss some claims in nationwide litigation over recalled baby formula.
Abbott (ABT) Expands in Electrophysiology With New FDA Nod
12:50pm, Monday, 22'nd May 2023
Abbott (ABT) notes that using TactiFlex catheter can lead to reduced procedure times and better safety compared to the company's previous generation catheters.
Abbott's (ABT) New Pact to Advance Clinical Trials Diversity
02:27pm, Monday, 15'th May 2023
Abbott's (ABT) latest additions to Diversity in Clinical Trials effort expand upon the alliances, awards and the emphasis on diverse participation in its own clinical trials.
